• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有内质网膜定位序列的蛋白质包封生物纳米胶囊的生产。

Protein-encapsulated bio-nanocapsules production with ER membrane localization sequences.

机构信息

Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, 1-1 Rokkodaicho, Nada-ku, Kobe 657-8501, Japan.

出版信息

J Biotechnol. 2012 Jan;157(1):124-9. doi: 10.1016/j.jbiotec.2011.09.015. Epub 2011 Sep 22.

DOI:10.1016/j.jbiotec.2011.09.015
PMID:21963589
Abstract

Bio-nanocapsules (BNCs) are hollow nanoparticles composed of the L protein of hepatitis B virus (HBV) surface antigen (HBsAg), which can specifically introduce genes and drugs into various kinds of target cells. Although the classic electroporation method has typically been used to introduce highly charged molecules such as DNA, it is rarely adopted for proteins due to its very low efficiency. In this study, a novel approach to the preparation of BNC was established whereby a target protein was pre-encapsulated during the course of nanoparticle formation. Briefly, because of the process of BNC formation in a budding manner on the endoplasmic reticulum (ER) membrane, the association of target proteins to the ER membrane with lipidation sequences (ER membrane localization sequences) could directly generate protein-encapsulating BNC in collaboration with co-expression of the L proteins. Since the membrane-localized proteins are automatically enveloped into BNCs during the budding event, this method can be protect the proteins and BNCs from damage caused by electroporation and obviate the need for laborious consideration to study the optimal conditions for protein encapsulation. This approach would be a useful method for encapsulating therapeutic candidate proteins into BNCs.

摘要

生物纳米胶囊(BNCs)是由乙型肝炎病毒(HBV)表面抗原(HBsAg)的 L 蛋白组成的中空纳米颗粒,它可以将基因和药物特异性地导入各种靶细胞。虽然经典的电穿孔法通常用于引入带高电荷的分子,如 DNA,但由于效率非常低,很少用于蛋白质。在本研究中,建立了一种制备 BNC 的新方法,其中在纳米颗粒形成过程中预先包封靶蛋白。简而言之,由于 BNC 以出芽的方式在内质网(ER)膜上形成,带有脂化序列(ER 膜定位序列)的靶蛋白与 ER 膜的结合可以直接生成与 L 蛋白共表达的蛋白包封的 BNC。由于在出芽事件中膜定位蛋白自动被包裹在 BNC 中,因此该方法可以保护蛋白和 BNC 免受电穿孔引起的损伤,并且无需费力考虑研究蛋白包封的最佳条件。该方法将是将治疗候选蛋白包封到 BNC 中的有用方法。

相似文献

1
Protein-encapsulated bio-nanocapsules production with ER membrane localization sequences.具有内质网膜定位序列的蛋白质包封生物纳米胶囊的生产。
J Biotechnol. 2012 Jan;157(1):124-9. doi: 10.1016/j.jbiotec.2011.09.015. Epub 2011 Sep 22.
2
Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.乙型肝炎病毒包膜 L 蛋白衍生的生物纳米胶囊:进入人肝细胞的细胞附着和进入机制。
J Control Release. 2012 Jun 10;160(2):322-9. doi: 10.1016/j.jconrel.2011.11.004. Epub 2011 Nov 10.
3
Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.从酿酒酵母中高效快速纯化携带药物和基因的生物纳米胶囊——乙型肝炎病毒表面抗原L颗粒。
Protein Expr Purif. 2011 Aug;78(2):149-55. doi: 10.1016/j.pep.2011.04.008. Epub 2011 Apr 14.
4
Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials.与脂质体结合的生物纳米胶囊用于体内各种物质的精准递送。
J Control Release. 2008 Mar 20;126(3):255-64. doi: 10.1016/j.jconrel.2007.12.002. Epub 2007 Dec 14.
5
Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.生物纳米胶囊脂质体复合物的细胞内运输:乙型肝炎病毒表面抗原 L 蛋白前 S1 区融合活性的鉴定。
J Control Release. 2015 Aug 28;212:10-8. doi: 10.1016/j.jconrel.2015.06.012. Epub 2015 Jun 12.
6
Electroporation and use of hepatitis B virus envelope L proteins as bionanocapsules.电穿孔法以及将乙肝病毒包膜L蛋白用作生物纳米胶囊
Cold Spring Harb Protoc. 2012 Jun 1;2012(6):702-5. doi: 10.1101/pdb.prot069534.
7
Secretory production system of bionanocapsules using a stably transfected insect cell line.利用稳定转染的昆虫细胞系构建生物纳米胶囊的分泌生产系统。
Appl Microbiol Biotechnol. 2006 Dec;73(3):505-11. doi: 10.1007/s00253-006-0486-3. Epub 2006 Jul 18.
8
Construction of arginine-rich peptide displaying bionanocapsules.展示富含精氨酸肽的生物纳米胶囊的构建。
Bioorg Med Chem Lett. 2009 Mar 1;19(5):1473-6. doi: 10.1016/j.bmcl.2009.01.049. Epub 2009 Jan 22.
9
Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.第8章——用于体内精准药物和基因递送的生物纳米胶囊-脂质体缀合物
Methods Enzymol. 2009;464:147-66. doi: 10.1016/S0076-6879(09)64008-8.
10
Targeting of polyplex to human hepatic cells by bio-nanocapsules, hepatitis B virus surface antigen L protein particles.生物纳米胶囊靶向人肝细胞,乙型肝炎病毒表面抗原 L 蛋白颗粒。
Bioorg Med Chem. 2012 Jun 15;20(12):3873-9. doi: 10.1016/j.bmc.2012.04.031. Epub 2012 Apr 21.

引用本文的文献

1
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles.将精氨酸残基进行突变以避免乙型肝炎病毒核心颗粒的非特异性细胞摄取。
J Nanobiotechnology. 2015 Feb 13;13:15. doi: 10.1186/s12951-015-0074-8.